Source: Annual Congress 2009 - Treatment of lung cancer
Disease area: Respiratory infections, Thoracic oncology

Abstract

Background. Lung cancer of in the advanced countries is guideing localization in structure of oncological diseases. It is established, that only in time the made surgical operation in an early stage of disease yields the good long-term results.
Aims. To define optimum volume of surgical treatment of pulmonary adenocarcinoma in 1a stage.
Materials and methods. Within 1963 on 2008 yy there 106 patients with pulmonary adenocarcinoma in 1a stage were treated, including 76 male and 30 female. The patients age varied from 25 to 74 years. In 103 cases it is diagnosed peripheral adenocarcinoma. In 3 cases there were central tumors. The diagnosis before operation was verified in 32 cases. All patients were operated. Lobectomy was performed in 86 cases (81,1 %). Precision resection and segmentectomy were made in 20 cases.
Results. Postoperative complications included 9 cases of residual cavity, 3 cases of pneumonia and 1 cases of lung abscess. Lethality rate was 0,9 %. Long-term results within 6 months to 33 years are studied for all patients. 5 years survival rate was 75,6 %.
Conclusions. To our opinion volume of resection does not influence on long-term survival rate. Optimum operation for 1a stage pulmonary adenocarcinoma is lobectomy however for patients with advanced accompanying diseases quite justified it is possible to consider a resection of easy smaller volume.

Rating:

Share or cite this content

Citations should be made in the following way:
V. Parshin, S. Grigorieva, H. Mirzoyan, D. Bazarov (Moscow, Russian Federation). Results of surgical management of pulmonary adenocarcinoma in 1a stage (T1N0M0): lessons learned. Eur Respir J 2009; 34: Suppl. 53, 2652

Member's Comments

No comment yet.

Related content which might interest you: Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification Source: Eur Respir J 2012; 39: 478-486 Year: 2012 Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Surgical management of rare malignant tumours of lungs: lessons learned Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 Early surgical resection for stage I high-grade neuroendocrine caricinoma of lung Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Occult N2 disease after surgical resection for clinical stage I NSCLC: factors affecting survival Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Sublobar resections vs lobectomy for early stage lung cancer: where do we stand? Source: Virtual Congress 2020 – Lung cancer screening: are we back to the individualised decision-making process? Year: 2020 Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer Source: Eur Respir J 2013; 42: 1119-1133 Year: 2013 Surgical and endoscopic management of patients with pulmonary emphysema in thoracic division: Lessons learned Source: Annual Congress 2010 - Video-assisted thorascopic surgery, novel technical devices and tracheal problems Year: 2010 Surgical management of early lung cancer: the surgeon's view Source: Annual Congress 2005 - PG16 - Detection of very early lesions in lung cancer: is this important and should they be treated? Year: 2005 Therapeutic options for operated adenocarcinoma patients in stages I or II Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Multimodality management of non-small cell lung cancer stage III: the pulmonologist as pilot and partner Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019 Year: 2020 Is surgical resection of M1a lung adenocarcinoma with metastatic pleural nodules really a useless choice? Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Surgery of lung cancer in elderly patients: lessons learned Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches Source: Virtual Congress 2021 – Thoracic oncology Year: 2021